Clinical Trial: A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07703878) titled 'A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors' on July 08.

Brief Summary: The goal of this clinical study is to learn more about the study drug GS-1206, including its safety, tolerability, and antitumor activity in adult participants with solid tumors.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Solid Tumor

Intervention: DRUG: GS-1206

Administered Orally

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Gilead Sciences

Published by HT Digital Content Services with permission from Health Daily Digest....